Transcatheter ablation: a turning point in anti-arrhythmia therapy
Critelli, G.
Cardiologia 38(10): 661-667
1993
ISSN/ISBN: 0393-1978 PMID: 8111759 Document Number: 420905
Document emailed within 1 workday
Related Documents
Dwyer, M.T. 1994: Transcatheter radiofrequency ablation for cardiac arrhythmia Medical Journal of Australia 160(3): 167Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Chen, F.F.; Zhao, Y.C.; Yin, X.M.; Liu, J.Q.; Xia, Y.L. 2019: Current status of catheter ablation for arrhythmia after cardiac resynchronization therapy in patients with chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 47(11): 927-930
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Salerno, J.A.; Klersy, C.; Minzioni, G.; Guasti, L.; Chimienti, M.; Zardini, M.; Viganò, M. 1988: Therapy of arrhythmia by ablation technics with catheters and with surgical technics Cardiologia 33(3): 237-241
Pestel, E. 1975: Mankind at the turning point South African Journal of Science 71(11): 329-333
Tekeuchi, T. 1972: Turning point in autopsy Rinsho Byori. Japanese Journal of Clinical Pathology 20(9): 655-657
Geibel, A.; Zehender, M.; Hohnloser, S.; Landsrath, C.; Meinertz, T.; Just, H. 1988: Diprafenone--comparative study of anti-arrhythmia therapy with propafenone Zeitschrift für Kardiologie 77(7): 464-469
Follath, F.; Candinas, R.; Frielingsdorf, J. 1993: Therapy of atrial fibrillation with class III anti-arrhythmia agents Herz 18(1): 20-26
Meyer, H. 2014: Obamacare's political turning point Modern Healthcare 44(35): 37
Kenéz, J. 1975: Turning-point in the diagnosis of syphilis Orvosi Hetilap 116(12): 695-701
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Honerjäger, P.; Schmidt, G. 1993: Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(9): 425-429
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Lishmanov, I.B.; Maslov, L.N.; Krylatov, A.V.; Ugdyzhekova, D.S.; Gilligan, P.; Tam, S.W. 2000: The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands Eksperimental'naia i Klinicheskaia Farmakologiia 63(2): 39-43
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70